Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

OBJECTIVE—We explored whether cardiovascular disease (CVD) risk and the effects of fenofibrate differed in subjects with and without metabolic syndrome and according to various features of metabolic syndrome defined by the Adult Treatment Panel III (ATP III) in subjects with type 2 diabetes in the F...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Format: Artigo
Sprog:Inglês
Udgivet: American Diabetes Association 2009
Fag:
Cardiovascular and Metabolic Risk
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2646035/
https://ncbi.nlm.nih.gov/pubmed/18984774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-1543
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker